Document detail
ID

doi:10.1186/s12887-024-04873-1...

Author
Malla, Lucas Ohuma, Eric O. Shabani, Josephine Ngwala, Samuel Dosunmu, Olabisi Wainaina, John Aluvaala, Jalemba Kassim, Irabi Cross, James H. Salim, Nahya Zimba, Evelyn Ezeaka, Chinyere Penzias, Rebecca E. Gathara, David Tillya, Robert Chiume, Msandeni Odedere, Opeyemi Lufesi, Norman Kawaza, Kondwani Irimu, Grace Tongo, Olukemi Murless-Collins, Sarah Bohne, Christine Richards-Kortum, Rebecca Oden, Maria Lawn, Joy E.
Langue
en
Editor

BioMed Central

Category

Medicine & Public Health

Year

2024

listing date

7/10/2024

Keywords
newborn low- and middle-income countries inpatient care covid interrupted time series neonatal mortality policies 2021 december malawi kenya containment nigeria significant overall effects inpatient decline april interruption neonatal march covid-19 2020 tanzania mortality admissions analysis
Metrics

Abstract

Background The emergence of COVID-19 precipitated containment policies (e.g., lockdowns, school closures, etc.).

These policies disrupted healthcare, potentially eroding gains for Sustainable Development Goals including for neonatal mortality.

Our analysis aimed to evaluate indirect effects of COVID-19 containment policies on neonatal admissions and mortality in 67 neonatal units across Kenya, Malawi, Nigeria, and Tanzania between January 2019 and December 2021.

Methods The Oxford Stringency Index was applied to quantify COVID-19 policy stringency over time for Kenya, Malawi, Nigeria, and Tanzania.

Stringency increased markedly between March and April 2020 for these four countries (although less so in Tanzania), therefore defining the point of interruption.

We used March as the primary interruption month, with April for sensitivity analysis.

Additional sensitivity analysis excluded data for March and April 2020, modelled the index as a continuous exposure, and examined models for each country.

To evaluate changes in neonatal admissions and mortality based on this interruption period, a mixed effects segmented regression was applied.

The unit of analysis was the neonatal unit ( n  = 67), with a total of 266,741 neonatal admissions (January 2019 to December 2021).

Results Admission to neonatal units decreased by 15% overall from February to March 2020, with half of the 67 neonatal units showing a decline in admissions.

Of the 34 neonatal units with a decline in admissions, 19 (28%) had a significant decrease of ≥ 20%.

The month-to-month decrease in admissions was approximately 2% on average from March 2020 to December 2021.

Despite the decline in admissions, we found no significant changes in overall inpatient neonatal mortality.

The three sensitivity analyses provided consistent findings.

Conclusion COVID-19 containment measures had an impact on neonatal admissions, but no significant change in overall inpatient neonatal mortality was detected.

Additional qualitative research in these facilities has explored possible reasons.

Strengthening healthcare systems to endure unexpected events, such as pandemics, is critical in continuing progress towards achieving Sustainable Development Goals, including reducing neonatal deaths to less than 12 per 1000 live births by 2030.

Malla, Lucas,Ohuma, Eric O.,Shabani, Josephine,Ngwala, Samuel,Dosunmu, Olabisi,Wainaina, John,Aluvaala, Jalemba,Kassim, Irabi,Cross, James H.,Salim, Nahya,Zimba, Evelyn,Ezeaka, Chinyere,Penzias, Rebecca E.,Gathara, David,Tillya, Robert,Chiume, Msandeni,Odedere, Opeyemi,Lufesi, Norman,Kawaza, Kondwani,Irimu, Grace,Tongo, Olukemi,Murless-Collins, Sarah,Bohne, Christine,Richards-Kortum, Rebecca,Oden, Maria,Lawn, Joy E., 2024, COVID-19 pandemic effects on neonatal inpatient admissions and mortality: interrupted time series analysis of facilities implementing NEST360 in Kenya, Malawi, Nigeria, and Tanzania, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder